UM

Browse/Search Results:  1-6 of 6 Help

Selected(0)Clear Items/Page:    Sort:
The p38 MAPK inhibitor SB203580 abrogates tumor necrosis factor-induced proliferative expansion of mouse CD4+Foxp3+ regulatory T cells Journal article
Frontiers in Immunology, 2018,Volume: 9,Issue: JUL
Authors:  He T.;  Liu S.;  Chen S.;  Ye J.;  Wu X.;  Bian Z.;  Chen X.
Favorite |  | TC[WOS]:25 TC[Scopus]:25 | Submit date:2018/11/06
cd4+foxp3+ Regulatory t Cells  P38 Mapk  Proliferation  Tnf Receptor Type Ii  Tumor Necrosis Factor  
The p38 MaPK inhibitor sB203580 abrogates Tumor necrosis Factor-induced Proliferative expansion of Mouse cD4(+)Foxp3(+) regulatory T cells Journal article
FRONTIERS IN IMMUNOLOGY, 2018,Volume: 9
Authors:  He, Tianzhen;  Liu, Shuoyang;  Chen, Shaokui;  Ye, Jingyi;  Wu, Xueqiang;  Bian, Zhaoxiang;  Chen, Xin
Favorite |  | TC[WOS]:25 TC[Scopus]:25 | Submit date:2018/10/30
Tumor Necrosis Factor  Tnf Receptor Type Ii  P38 Mapk  Cd4(+)Foxp3(+) Regulatory t Cells  Proliferation  
TNF Receptor Type II as an Emerging Drug Target for the Treatment of Cancer, Autoimmune Diseases, and Graft-Versus-Host Disease: Current Perspectives and In Silico Search for Small Molecule Binders Journal article
FRONTIERS IN IMMUNOLOGY, 2018,Volume: 9
Authors:  Shaikh, Faraz;  He, Jiang;  Bhadra, Pratiti;  Chen, Xin;  Siu, Shirley W., I
Favorite |  | TC[WOS]:11 TC[Scopus]:13 | Submit date:2018/10/30
Tnf Receptor Type Ii  Tnf  Regulatory t Cells  Virtual Screening  Drug Discovery  Mm-pbsa  
TNF receptor type II as an emerging drug target for the treatment of cancer, autoimmune diseases, and graft-versus-host disease: Current perspectives and in silico search for small molecule binders Journal article
Frontiers in Immunology, 2018,Volume: 9,Issue: JUN
Authors:  Shaikh F.;  He J.;  Bhadra P.;  Chen X.;  Siu S.W.
Favorite |  | TC[WOS]:11 TC[Scopus]:13 | Submit date:2019/04/04
Drug Discovery  Mm-pbsa  Regulatory t Cells  Tnf  Tnf Receptor Type Ii  Virtual Screening  
Modulation of Regulatory T Cell Activity by TNF Receptor Type II-Targeting Pharmacological Agents Journal article
FRONTIERS IN IMMUNOLOGY, 2018,Volume: 9
Authors:  Zou, Huimin;  Li, Ruixin;  Hu, Hao;  Hu, Yuanjia;  Chen, Xin
Favorite |  | TC[WOS]:34 TC[Scopus]:34 | Submit date:2018/10/30
Tnf Receptor Type Ii  Regulatory t Cells  Tnf Receptor Type Ii Agonists  Tnf Receptor Type Ii Antagonists  Immunotherapy  
In vitro generated Th17 cells support the expansion and phenotypic stability of CD4(+)Foxp3(+) regulatory T cells in vivo. Journal article
Cytokine, 2014,Page: 56-64
Authors:  Zhou, Q.;  Hu, Y.;  Howard, O.;  Oppenheim, J.;  Chen, X.
Favorite |  | TC[WOS]:0 TC[Scopus]:0 | Submit date:2022/08/30
FoxP3  IL-2  KI  KO  Regulatory T cell  TNF  TNFR2  TNFR2 Fc fusion protein  TNFR2-Fc  Teffs  Th17  Tregs  effector T cells  forkhead box P3  knock in  knock out  nCD4  naïve CD4 cells  regulatory T cells  tumor necrosis factor receptor type II